|
US3755560A
(en)
|
1971-06-30 |
1973-08-28 |
Dow Chemical Co |
Nongreasy cosmetic lotions
|
|
DE2437090A1
(de)
|
1974-08-01 |
1976-02-19 |
Hoechst Ag |
Reinigungsmittel
|
|
US4421769A
(en)
|
1981-09-29 |
1983-12-20 |
The Procter & Gamble Company |
Skin conditioning composition
|
|
US4666828A
(en)
|
1984-08-15 |
1987-05-19 |
The General Hospital Corporation |
Test for Huntington's disease
|
|
US4683202A
(en)
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
|
US4801531A
(en)
|
1985-04-17 |
1989-01-31 |
Biotechnology Research Partners, Ltd. |
Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
|
|
US4929442A
(en)
*
|
1986-09-26 |
1990-05-29 |
Exovir, Inc. |
Compositions suitable for human topical application including a growth factor and/or related materials
|
|
US5124155A
(en)
|
1988-06-21 |
1992-06-23 |
Chiron Ophthalmics, Inc. |
Fibronectin wound-healing dressings
|
|
US5272057A
(en)
|
1988-10-14 |
1993-12-21 |
Georgetown University |
Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
|
|
US5264214A
(en)
|
1988-11-21 |
1993-11-23 |
Collagen Corporation |
Composition for bone repair
|
|
US5192659A
(en)
|
1989-08-25 |
1993-03-09 |
Genetype Ag |
Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
|
|
US5073372A
(en)
|
1990-11-30 |
1991-12-17 |
Richardson-Vicks, Inc. |
Leave-on facial emulsion compositions
|
|
US5073371A
(en)
|
1990-11-30 |
1991-12-17 |
Richardson-Vicks, Inc. |
Leave-on facial emulsion compositions
|
|
US5564345A
(en)
*
|
1993-05-11 |
1996-10-15 |
Park Ohio Industries Inc. |
Stackable table, table assembly, and tray and table combination
|
|
WO1994013692A1
(en)
*
|
1992-12-10 |
1994-06-23 |
Regents Of The University Of Minnesota |
Polypeptides useful for treating inflammatory disorders
|
|
GB9315810D0
(en)
*
|
1993-07-30 |
1993-09-15 |
Univ London |
Stabilised materials
|
|
US7112320B1
(en)
*
|
1995-06-07 |
2006-09-26 |
Andre Beaulieu |
Solid wound healing formulations containing fibronectin
|
|
US6458889B1
(en)
*
|
1995-12-18 |
2002-10-01 |
Cohesion Technologies, Inc. |
Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use
|
|
US6007802A
(en)
|
1996-03-27 |
1999-12-28 |
The Procter & Gamble Co. |
Conditioning shampoo composition
|
|
WO1998040045A1
(fr)
*
|
1997-03-11 |
1998-09-17 |
Pola Chemical Industries Inc. |
Procede d'evaluation d'agents de revitalisation et procede de production de preparations externes pour la peau
|
|
CA2232855C
(en)
*
|
1997-04-10 |
2007-10-09 |
Roche Consumer Health (Worldwide) Sa |
Pharmaceutical formulation
|
|
CA2316015A1
(en)
*
|
1997-12-22 |
1999-07-01 |
Human Genome Sciences, Inc. |
Keratinocyte growth factor-2 formulations
|
|
US6194378B1
(en)
*
|
1998-02-18 |
2001-02-27 |
The Research Foundation Of State University Of New York |
Fibronectin peptides-based extracellular matrix for wound healing
|
|
GB9804720D0
(en)
|
1998-03-05 |
1998-04-29 |
Unilever Plc |
Shampoo compositions
|
|
JP2003513682A
(ja)
|
1998-07-24 |
2003-04-15 |
ファーマカル、バイオテクノロジーズ、インコーポレーテッド |
骨組織復元システムおよび方法
|
|
US20020006418A1
(en)
*
|
1998-10-13 |
2002-01-17 |
John Kung |
Composition to enhance permeation of topical skin agents
|
|
US20070129282A1
(en)
|
1998-11-24 |
2007-06-07 |
Ahlem Clarence N |
Pharmaceutical treatments and compositions
|
|
US20030072737A1
(en)
|
2000-12-29 |
2003-04-17 |
Michael Brines |
Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs
|
|
US6960173B2
(en)
|
2001-01-30 |
2005-11-01 |
Eilaz Babaev |
Ultrasound wound treatment method and device using standing waves
|
|
US6585963B1
(en)
*
|
2001-02-15 |
2003-07-01 |
Watson Pharmaceuticals, Inc. |
Nail compositions and methods of administering same
|
|
US6913762B2
(en)
|
2001-04-25 |
2005-07-05 |
Mayo Foundation For Medical Education And Research |
Stent having non-woven framework containing cells
|
|
US20030147825A1
(en)
*
|
2001-06-08 |
2003-08-07 |
Chiarelli Joseph A. |
Personal care compostions containing inverse emulsion polymers
|
|
US20030068297A1
(en)
*
|
2001-08-18 |
2003-04-10 |
Deepak Jain |
Composition and methods for skin rejuvenation and repair
|
|
US20040265268A1
(en)
*
|
2001-08-18 |
2004-12-30 |
Deepak Jain |
Compositions and methods for skin rejuvenation and repair
|
|
US7651684B2
(en)
|
2001-12-07 |
2010-01-26 |
Cytori Therapeutics, Inc. |
Methods of using adipose tissue-derived cells in augmenting autologous fat transfer
|
|
WO2003072748A2
(en)
|
2002-02-22 |
2003-09-04 |
University Of Washington |
Bioengineered tissue substitutes
|
|
JPWO2003103703A1
(ja)
|
2002-06-06 |
2005-10-06 |
中外製薬株式会社 |
骨代謝疾患治療剤
|
|
EP1517988B1
(de)
|
2002-06-20 |
2013-05-08 |
Augustinus Bader |
Verwendung von Erythropoietin zur Geweberegeneration in vivo
|
|
DE10234192B4
(de)
*
|
2002-07-26 |
2009-11-26 |
Epoplus Gmbh Co.Kg |
Verwendung von Erythropoetin
|
|
DE10303584A1
(de)
|
2003-01-30 |
2004-08-12 |
Stauss, Robert, Dr. |
Verwendung von Erythropoietin (EPO) als ein Beschichtungsmaterial auf medizinischen Implantaten
|
|
EP1601757B1
(en)
|
2003-02-24 |
2016-11-30 |
Marine Polymer Technologies, Inc. |
Cell-polymer fiber compositions and use thereof
|
|
US7459152B2
(en)
|
2003-04-23 |
2008-12-02 |
Rush University Medical Center |
Erythropoietin administration to improve graft survival
|
|
EP1673102A1
(en)
*
|
2003-10-17 |
2006-06-28 |
Crucell Holland B.V. |
Treatment and prevention of decubitus
|
|
WO2005065079A2
(en)
|
2003-11-10 |
2005-07-21 |
Angiotech International Ag |
Medical implants and fibrosis-inducing agents
|
|
EP1550715A1
(de)
|
2003-12-30 |
2005-07-06 |
Bionethos Holding Gmbh |
Verfahren zur Regenation von Gewebe
|
|
ES2346226T3
(es)
|
2003-12-30 |
2010-10-13 |
Augustinus Bader |
Uso de la eritropoyetina para la regeneracion de tejido hepatico.
|
|
US20050187158A1
(en)
*
|
2004-01-22 |
2005-08-25 |
Ranby Mats G. |
Pharmaceutical composition
|
|
DE102004063927A1
(de)
|
2004-01-23 |
2005-12-15 |
Epoplus Gmbh Co.Kg |
Einsatz von niedrig dosiertem Erythropoietin zur Stimulation endothelialer Vorläuferzellen sowie zur Organregeneration und Progressionsverlangsamung von Endorganschäden
|
|
US7473678B2
(en)
|
2004-10-14 |
2009-01-06 |
Biomimetic Therapeutics, Inc. |
Platelet-derived growth factor compositions and methods of use thereof
|
|
EP1865982A1
(en)
*
|
2005-04-06 |
2007-12-19 |
Bioartificial Gel Technologies Inc. |
Hydrogel composition for modulation of topical inflammatory response
|
|
DE102005019712A1
(de)
*
|
2005-04-28 |
2006-11-09 |
Bayer Healthcare Ag |
Dipyridyl-dihydropyrazolone und ihre Verwendung
|
|
AU2006245282A1
(en)
*
|
2005-05-10 |
2006-11-16 |
Dermipsor Ltd. |
Compositions and methods for skin care
|
|
US7312198B2
(en)
*
|
2005-07-12 |
2007-12-25 |
Essential Skincare, Llc |
Protein compositions for promoting wound healing and skin regeneration
|
|
EP1942928A2
(en)
|
2005-10-31 |
2008-07-16 |
Essential Skincare, LLC |
Protein composition for promoting wound healing and skin regeneration
|
|
US8361781B2
(en)
|
2006-01-24 |
2013-01-29 |
Brown University |
Cell aggregation and encapsulation device and method
|
|
WO2008020329A2
(en)
*
|
2006-05-11 |
2008-02-21 |
Regenics As |
Administration of cells and cellular extracts for rejuvenation
|
|
TWI409081B
(zh)
*
|
2006-11-09 |
2013-09-21 |
Alcon Res Ltd |
用於藥物輸送之水不溶性聚合物基質
|
|
US7717855B2
(en)
*
|
2006-12-06 |
2010-05-18 |
The Hospital For Sick Children |
System for performing remote ischemic preconditioning
|
|
EP2337544A2
(en)
*
|
2007-04-30 |
2011-06-29 |
Living Proof, Inc. |
Use of matrix metalloproteinase inhibitors in skin care
|
|
WO2008157733A2
(en)
|
2007-06-19 |
2008-12-24 |
Baxter International Inc. |
Fibrin gel for controlled release of pdgf and uses thereof
|
|
EP2018835B1
(de)
*
|
2007-07-09 |
2014-03-05 |
Augustinus Bader |
Wirkstoff abgebendes Pflaster
|
|
US20090045968A1
(en)
|
2007-08-16 |
2009-02-19 |
Optimal Innovations Inc. |
Utility Outlets Capable of Presenting Images
|
|
WO2009083203A2
(de)
|
2007-12-28 |
2009-07-09 |
Heraeus Kulzer Gmbh |
Topische anwendung und formulierung von erythropoietin für die wundheilung der haut
|
|
WO2009093240A2
(en)
|
2008-01-24 |
2009-07-30 |
Ademex Ltd. |
Erythropoietin and fibronectin compositions for bone regeneration
|